130 related articles for article (PubMed ID: 28743405)
1. Miliary tuberculosis during adalimumab therapy in Crohn's disease.
Ameneiros-Lago E; Vázquez Bueno JA; Garrido Sanjuan JA
Med Clin (Barc); 2018 May; 150(10):412. PubMed ID: 28743405
[No Abstract] [Full Text] [Related]
2. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn's disease: Report of three cases.
Bernardes C; Carvalho D; Saiote J; Ramos J
Gastroenterol Hepatol; 2018; 41(7):442-443. PubMed ID: 29054318
[No Abstract] [Full Text] [Related]
3. [Tuberculous liver abscess, anti-TNF alpha, and immune reconstitution inflammatory syndrome].
Dussouillez G; Zayet S; Kone D; Royer PY; Toko-Tchuindzie L; Ruyer O; Gendrin V
Med Mal Infect; 2020 Feb; 50(1):90-91. PubMed ID: 31477453
[No Abstract] [Full Text] [Related]
4. Ramsay-Hunt Syndrome in a patient with Crohn's disease under adalimumab: first case report.
Santos-Antunes J; Nunes AC; Macedo G
Gastroenterol Hepatol; 2015; 38(7):443-4. PubMed ID: 25081200
[No Abstract] [Full Text] [Related]
5. Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment.
Ikuta K; Ota Y; Kuroki S; Matsumoto Y; Senda E; Mukohara S; Takahashi S; Monden K; Fukuda A; Seno H; Kumagai S; Shio S
Intern Med; 2020 Mar; 59(6):849-853. PubMed ID: 31761884
[TBL] [Abstract][Full Text] [Related]
6. [Miliary tuberculosis in a patient with morbus Bechterew treated with tumour necrosis factor-alpha].
Lund-Andersen C; Grove M; Rasmussen K
Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497646
[TBL] [Abstract][Full Text] [Related]
7. Acute tubulointerstitial nephritis in an HLA-B27-positive patient with axial spondyloarthritis being treated with adalimumab.
Castro Corredor D; Sánchez de la Nieta MD; de Lara Simón IM
Reumatol Clin (Engl Ed); 2019; 15(3):179-181. PubMed ID: 28624373
[TBL] [Abstract][Full Text] [Related]
8. The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature.
Scrivo R; Sauzullo I; Mengoni F; Riccieri V; Altieri AM; Cantoro L; Vullo V; Mastroianni CM; Valesini G
Clin Rheumatol; 2016 May; 35(5):1383-8. PubMed ID: 24827875
[TBL] [Abstract][Full Text] [Related]
9. [Miliary tuberculosis in a patient with Crohn's disease].
Ferrer I; Maroto N; Montón C; Villagrasa R; López A; Clofent J; Hinojosa J
Gastroenterol Hepatol; 2011; 34(7):511-3. PubMed ID: 21737181
[No Abstract] [Full Text] [Related]
10. Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.
Hunt WTN; Wheeler JF; Kennedy NA; Burden T; McGrath EJ
Clin Exp Dermatol; 2021 Jan; 46(1):216-218. PubMed ID: 32931629
[No Abstract] [Full Text] [Related]
11. Asymptomatic choroidal tubercle in a patient with Crohn's disease on adalimumab treatment.
Asensio-Sánchez VM; Díaz-Cabanas L; Martín-Prieto A; Haro-Álvarez B
Arch Soc Esp Oftalmol (Engl Ed); 2018 Mar; 93(3):147-150. PubMed ID: 28743416
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
Ferrer Bradley I; Maroto Arce N; Mora Escrig M; Hinojosa Del Val J
Gastroenterol Hepatol; 2019; 42(6):387-388. PubMed ID: 30042000
[No Abstract] [Full Text] [Related]
13. Tuberculous monoarthritis after treatment with adalimumab in Crohn's disease.
Martínez-Caselles A; Martínez-Pascual C; Muñoz-Tornero M; Sánchez-Torres A; Carballo-Álvarez F
Rev Esp Enferm Dig; 2012 Mar; 104(3):157-8. PubMed ID: 22449164
[No Abstract] [Full Text] [Related]
14. Adalimumab-induced acute myeloid leukaemia in a patient with Crohn's disease.
Alzahrani T; Nuqali A; Naser N; Jariwala AR
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30718264
[TBL] [Abstract][Full Text] [Related]
15. [Fatal miliary tuberculosis during treatment with infliximab].
Vonkeman HE; van der Valk PD; Mulder L; van de Laar MA
Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1196-9. PubMed ID: 12109312
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials.
Huang ML; Ran ZH; Shen J; Li XB; Xu XT; Xiao SD
J Dig Dis; 2011 Jun; 12(3):165-72. PubMed ID: 21615869
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy onset in a Crohn's disease patient treated with Adalimumab.
Bruzzese V; Lorenzetti R; Rosa M; Di Giulio S; Hassan C; Costas G; Zullo A
Minerva Gastroenterol Dietol; 2016 Jun; 62(2):223-4. PubMed ID: 27091038
[No Abstract] [Full Text] [Related]
18. Anti-TNF treatment and miliary tuberculosis in Crohn's disease.
Milenković B; Dudvarski-Ilić A; Janković G; Martinović L; Mijac D
Srp Arh Celok Lek; 2011; 139(7-8):514-7. PubMed ID: 21980664
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
[No Abstract] [Full Text] [Related]
20. Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy.
Takahashi G; Kobayashi H; Saito Y; Ohsawa S; Suzuki K; Ishihara S; Hisada T
Intern Med; 2019 Dec; 58(24):3593-3596. PubMed ID: 31434822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
